Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms

Correction to: J Neural Transm https://doi.org/10.1007/s00702-017-1791-y

Unfortunately, Author has now noticed two mistakes in Fig. 1. Author has written “peripher” instead of “peripheral” and “Secundary” instead of “Secondary”.

The revised figure is placed in the following page.

Fig. 1
figure1

Primary and secondary causes of nOH according to the site of lesion—schematic representation. AAG autoimmune autonomic ganglionopathy, AAN autoimmune autonomic neuropathy, ADLD autosomal dominant leukodystrophy, CRF chronic renal failure, DBH deficiency dopamine-β-hydroxylase deficiency, DM diabetes mellitus, FD familial dysautonomia (=hereditary sensory and autonomic neuropathy type III, Riley-Day syndrome), LBD Lewy-body dementia, MS multiple sclerosis, MSA multiple system atrophy, nOH neurogenic orthostatic hypotension, PAF pure autonomic failure, PD Parkinson’s disease

Author information

Correspondence to Alessandra Fanciulli.

Additional information

The online version of the original article can be found under https://doi.org/10.1007/s00702-017-1791-y.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eschlböck, S., Wenning, G. & Fanciulli, A. Correction to: Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm 125, 273–274 (2018). https://doi.org/10.1007/s00702-017-1814-8

Download citation